Brazil approves Pfizer COVID-19 vaccine for children over 12
SAO PAULO (Reuters) - Brazil health regulator Anvisa on Friday said it had approved use of the Pfizer/BioNtech COVID-19 vaccine for children over 12 years of age.
(Reporting by Eduardo Simoes; Editing by Alex Richardson)
© Copyright Reuters Ltd. All rights reserved. The information contained in this news report may not be published, broadcast or otherwise distributed without the prior written authority of Reuters Ltd.